Wird geladen...

How Abbott’s Fenofibrate Franchise Avoided Generic Competition

The ongoing debate concerning the efficacy of fenofibrate has overshadowed an important aspect of the drug’s history: Abbott, the maker of branded fenofibrate, has produced several bioequivalent reformulations, which dominate the market even though generic fenofibrate has been available for almost a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Downing, Nicholas S., Ross, Joseph S., Jackevicius, Cynthia A., Krumholz, Harlan M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2012
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3636774/
https://ncbi.nlm.nih.gov/pubmed/22493409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archinternmed.2012.187
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!